Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA.

Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5.

PMID:
23648805
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies.

Madigan D, Ryan PB, Schuemie M.

Ther Adv Drug Saf. 2013 Apr;4(2):53-62. doi: 10.1177/2042098613477445.

PMID:
25083251
[PubMed]
Free PMC Article
3.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

PMID:
21132580
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Anglemyer A, Horvath HT, Bero L.

Cochrane Database Syst Rev. 2014 Apr 29;4:MR000034. doi: 10.1002/14651858.MR000034.pub2.

PMID:
24782322
[PubMed - in process]
5.

Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system.

Norén GN, Bergvall T, Ryan PB, Juhlin K, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S107-21. doi: 10.1007/s40264-013-0095-x.

PMID:
24166228
[PubMed - indexed for MEDLINE]
6.

Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Stang PE, Ryan PB, Overhage JM, Schuemie MJ, Hartzema AG, Welebob E.

Drug Saf. 2013 Oct;36 Suppl 1:S15-25. doi: 10.1007/s40264-013-0103-1.

PMID:
24166220
[PubMed - indexed for MEDLINE]
7.

Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system.

Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S83-93. doi: 10.1007/s40264-013-0100-4.

PMID:
24166226
[PubMed - indexed for MEDLINE]
8.

Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.

Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, van der Lei J, Sturkenboom MC.

Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8.

PMID:
24166232
[PubMed - indexed for MEDLINE]
10.

Evaluating performance of risk identification methods through a large-scale simulation of observational data.

Ryan PB, Schuemie MJ.

Drug Saf. 2013 Oct;36 Suppl 1:S171-80. doi: 10.1007/s40264-013-0110-2.

PMID:
24166233
[PubMed - indexed for MEDLINE]
11.

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.

Savović J, Jones H, Altman D, Harris R, Jűni P, Pildal J, Als-Nielsen B, Balk E, Gluud C, Gluud L, Ioannidis J, Schulz K, Beynon R, Welton N, Wood L, Moher D, Deeks J, Sterne J.

Health Technol Assess. 2012 Sep;16(35):1-82. Review.

PMID:
22989478
[PubMed - indexed for MEDLINE]
Free Article
12.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

PMID:
15361314
[PubMed - indexed for MEDLINE]
Free Article
13.

From randomized controlled trials to observational studies.

Silverman SL.

Am J Med. 2009 Feb;122(2):114-20. doi: 10.1016/j.amjmed.2008.09.030. Review.

PMID:
19185083
[PubMed - indexed for MEDLINE]
14.

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9.

PMID:
24166231
[PubMed - indexed for MEDLINE]
15.

Emerging methods in comparative effectiveness and safety: symposium overview and summary.

Lohr KN.

Med Care. 2007 Oct;45(10 Supl 2):S5-8.

PMID:
17909383
[PubMed - indexed for MEDLINE]
16.

Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.

Ryan PB, Schuemie MJ, Madigan D.

Drug Saf. 2013 Oct;36 Suppl 1:S95-106. doi: 10.1007/s40264-013-0101-3.

PMID:
24166227
[PubMed - indexed for MEDLINE]
17.

An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.

Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C, Bate A.

Drug Saf. 2013 Feb;36(2):119-34. doi: 10.1007/s40264-012-0009-3.

PMID:
23329543
[PubMed - indexed for MEDLINE]
18.

Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.

Parker D, Mills S, Abbey J.

Int J Evid Based Healthc. 2008 Jun;6(2):137-72. doi: 10.1111/j.1744-1609.2008.00090.x.

PMID:
21631819
[PubMed]
19.

A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases.

Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, Martin BC, Stang P.

Value Health. 2003 Mar-Apr;6(2):90-7.

PMID:
12641858
[PubMed - indexed for MEDLINE]
20.

The Jepson Lecture 1991. Clinical databases and surgical research.

Little JM.

Aust N Z J Surg. 1992 May;62(5):327-32.

PMID:
1575652
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk